CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 43 filers reported holding CORVUS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25 | -56.9% | 17,366 | -32.0% | 0.00% | -50.0% |
| Q2 2023 | $58 | +222.2% | 25,542 | +32.0% | 0.00% | +100.0% |
| Q1 2023 | $18 | +12.5% | 19,354 | +3.2% | 0.00% | 0.0% |
| Q4 2022 | $16 | -99.9% | 18,758 | +31.5% | 0.00% | 0.0% |
| Q1 2022 | $23,000 | -75.8% | 14,269 | -27.5% | 0.00% | -75.0% |
| Q3 2021 | $95,000 | -41.7% | 19,688 | +92.9% | 0.01% | 0.0% |
| Q3 2017 | $163,000 | – | 10,205 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 3,749,379 | $18,147,000 | 3.77% |
| VR Adviser, LLC | 3,427,461 | $16,589,000 | 2.13% |
| ADAMS STREET PARTNERS LLC | 3,275,616 | $15,854,000 | 2.04% |
| Telemetry Investments, L.L.C. | 196,168 | $949,000 | 1.28% |
| DC Investments Management, LLC | 50,709 | $245,000 | 0.46% |
| Orbimed Advisors | 6,943,654 | $33,607,000 | 0.37% |
| EcoR1 Capital, LLC | 2,081,077 | $10,072,000 | 0.35% |
| BVF INC/IL | 1,370,947 | $6,635,000 | 0.26% |
| Ikarian Capital, LLC | 757,545 | $3,666,000 | 0.26% |
| CHI Advisors LLC | 165,927 | $803,000 | 0.23% |